Supplement Compliance Risks: What Can Go Wrong

Last reviewed: April 1, 2026 | Next review: October 1, 2026

By Greg Huang, Founder of multiple consumer brands in the dietary supplement and nutrition industry since 2009

Reviewed by Dr. James Pendleton, ND, licensed primary care physician, 20+ years in naturopathic medicine

No manufacturer will tell you about the things that go wrong. This guide covers real enforcement actions, the most common compliance failures, and what they cost. Understanding these risks is part of evaluating any manufacturing partner.

Dietary supplement manufacturers must comply with 21 CFR Part 111 (Current Good Manufacturing Practice for dietary supplements). This includes requirements for personnel, facilities, equipment, production, laboratory operations, and record-keeping.

Who Enforces Supplement Regulations

FDA (Food and Drug Administration)

Scope: Manufacturing compliance, cGMP, facility inspections, adulteration, misbranding, recalls

Enforcement power: Warning letters, import alerts, injunctions, seizures, criminal prosecution. Can shut down a facility.

FTC (Federal Trade Commission)

Scope: Advertising and marketing claims, including social media, influencer content, and affiliate marketing. Any claim about what a supplement does must be truthful and substantiated. FTC and FDA coordinate enforcement under a formal liaison agreement, meaning advertising violations can trigger manufacturing facility scrutiny and vice versa.

Enforcement power: Penalties up to $53,088 per violation per day (source: FTC 2025 inflation-adjusted civil penalty amounts). Consent decrees, refund orders, and advertising bans.

State Attorneys General

Scope: Consumer protection, state-specific labeling requirements (California Prop 65), state advertising laws.

Enforcement power: Lawsuits, penalties, injunctions. Multi-state coordinated actions are increasingly common.

The Most Common Violations

FDA inspections of dietary supplement facilities result in Form 483 observations. These are the most frequently cited violations. If your manufacturer can't demonstrate compliance in these areas, that's a significant risk.

Violation	CFR Reference	What It Means for You
No identity testing on incoming ingredients	21 CFR 111.75(a)(1)	You don't know what's actually in your product. Could be wrong ingredient, contaminated, or adulterated.
Incomplete batch production records	21 CFR 111.255	If a problem arises, there's no way to trace it. Recall becomes a guessing game.
No written procedures for quality control	21 CFR 111.103	Quality depends on whoever is working that day, not on consistent processes.
Failure to hold product pending testing results	21 CFR 111.123	Product ships before testing confirms it's safe. If results come back bad, it's already in consumers' hands.
Inadequate equipment cleaning between products	21 CFR 111.27	Cross-contamination between products. Allergen risk. Potency problems.

Real Consequences: What Enforcement Looks Like

These are not hypothetical scenarios. They are categories of enforcement actions that happen regularly in the supplement industry.

Warning Letters

The FDA regularly issues warning letters to supplement companies for cGMP violations and unauthorized health claims. These are public documents. They appear in search results. Retailers check them. A warning letter on your manufacturer's record raises questions about every product they make.

Direct cost: $0 (it's a letter). Real cost: lost retailer relationships, consumer trust damage, and legal review expenses ranging from $5,000 to $20,000 or more according to industry estimates.

Product Recalls

The FDA can request voluntary recalls or, in rare cases, mandate them. Common triggers: undeclared allergens, contamination with harmful substances, and products containing unapproved drug ingredients. The brand's name is on the recall notice, not the manufacturer's.

According to industry estimates, recall costs typically range from $30,000 to $100,000 or more, though costs vary widely based on scope. Typical expenses include product retrieval, testing, consumer notification, legal fees, and lost inventory.

FTC Marketing Actions

The FTC targets deceptive advertising claims. "Boosts immunity," "burns fat," "prevents disease" without adequate scientific evidence are common triggers. In April 2023, the FTC issued Notices of Penalty Offenses to approximately 670 companies marketing health-related products including dietary supplements (FTC, April 13, 2023). In 2026, social media content and influencer marketing are fully in scope for FTC enforcement. The FTC and FDA coordinate enforcement under their liaison agreement, and FTC-FDA referrals mean a deceptive advertising case can escalate to manufacturing facility scrutiny. Influencer scripts, affiliate content, and user-generated testimonials that imply health benefits all carry the same liability as traditional advertising.

Penalties up to $53,088 per violation per day (source: FTC 2025 inflation-adjusted civil penalty amounts). A single advertising campaign can generate thousands of individual violations.

Prop 65 Lawsuits

California's Proposition 65 requires warnings for products containing chemicals known to cause cancer or reproductive harm. Private plaintiffs (bounty hunters) can sue for violations. In 2025, Proposition 65 enforcement resulted in 293 in-court settlements totaling $19.85 million across all product categories according to California AG Proposition 65 annual settlement reports. Dietary supplements and food products have consistently accounted for roughly half of all Prop 65 enforcement actions according to Bureau Veritas Q1 2025 Prop 65 analysis. Supplement-specific settlement amounts are not reported separately.

Settlement: $25,000 to $100,000 or more per case according to California AG settlement reports and Spencer Fane's 2026 Prop 65 analysis. Legal defense: $15,000+. Ongoing testing to prevent recurrence: $2,000 to $5,000 per batch (source: industry laboratory pricing surveys).

How to Protect Your Brand

Check your manufacturer's FDA record before signing. Search the FDA warning letters database, request their most recent 483 observations, and ask for their corrective action responses.
Get a quality agreement separate from the manufacturing agreement. This document defines testing requirements, specification limits, deviation procedures, and dispute resolution. It should specify who bears the cost of failed batches.
Require third-party COAs for every batch. In-house testing is a start. Independent verification catches what in-house testing misses. This is your evidence if a problem arises.
Have your marketing claims reviewed by a regulatory attorney. Before you make any health-related claims. Not after you get the FTC letter. A review costs $2,000 to $5,000. An FTC action costs $50,000+.
Carry product liability insurance. Minimum $1 million per occurrence, $2 million aggregate (source: industry-standard supplement policy minimums). Most retailers require this. Your manufacturer should carry their own policy as well.
Test for heavy metals if selling in California. Prop 65 lawsuits are a business risk. Proactive heavy metals testing is cheaper than reactive litigation.

Emerging Regulatory Trends (2026)

The regulatory landscape is shifting in several directions simultaneously. Brand owners should monitor these developments.

State Age Restrictions on Supplement Sales

New York enacted age verification requirements for weight loss and muscle-building supplements (General Business Law Section 391-oo, effective April 22, 2024). Michigan, Illinois, Massachusetts, and New Jersey have introduced similar bills. A federal court declined to block the New York law, and the Second Circuit affirmed that decision in November 2025, though the legal challenge on First Amendment grounds continues. Brands selling in these categories should prepare for state-by-state age verification at the point of sale.

THC Compliance Standards

New federal standards taking effect November 12, 2026 set statutory limits for total THC in hemp-derived products including dietary supplements: per Section 781 of H.R. 5371, maximum 0.3% total THC by dry weight and 0.4 milligrams total per container. “Total THC” includes delta-9, THCA, and other cannabinoids with similar effects, not just delta-9 alone. Products exceeding these limits become controlled substances under federal law, risking enforcement action, product removal, and potential criminal penalties under the Controlled Substances Act. Brands using hemp-derived ingredients should verify total THC levels through third-party testing well before the November 2026 deadline.

Drug Preclusion and Ingredient Status

The FDA's drug preclusion doctrine prevents certain ingredients from being marketed as dietary supplements if they were first authorized for investigation or approved as drugs. On September 29, 2025, the FDA reversed its position on NMN (nicotinamide mononucleotide), confirming it is lawful in dietary supplements after determining that NMN was marketed as a supplement before it was authorized for drug investigation (NPA, September 2025; Venable LLP, October 2025). NMN remains classified as a New Dietary Ingredient, and companies must file a New Dietary Ingredient Notification (NDIN) with the FDA at least 75 days before marketing NMN products. CBD (cannabidiol) remains excluded under drug preclusion because it was authorized for investigation as a drug (Epidiolex) before being marketed as a supplement. In March 2026, FDA submitted a “CBD Products Compliance and Enforcement Policy” to the White House OIRA for review, which may signal a regulatory pathway, but as of April 2026 no final policy has been published. Brands should not formulate with CBD until the regulatory status is resolved. Ingredient regulatory status can change; verify current status before formulation and monitor FDA guidance.

Retailers as De Facto Regulators

Major retailers including Amazon and Walmart have established proprietary standards that go beyond FDA requirements: sustainable packaging, "clean" labeling, restricted ingredient lists, and mandatory third-party certifications. Compliance with FDA standards alone may no longer be sufficient for market access. Brands selling through major retail channels should track retailer-specific requirements alongside federal regulations.

Frequently Asked Questions

What happens if the FDA sends my manufacturer a warning letter?

An FDA warning letter means the agency found significant cGMP violations during inspection. FDA recommends that the manufacturer respond within 15 business days with a corrective action plan (this is guidance, not a statutory deadline, but failing to respond promptly increases the likelihood of further enforcement). If they don't fix the issues, FDA can pursue injunctions, seizures, or prosecution. As the brand owner, you need to assess whether your products were affected and whether to continue the manufacturing relationship.

Can the FTC fine me for supplement marketing claims?

Yes. The FTC can impose penalties up to $53,088 per violation per day (source: FTC 2025 inflation-adjusted civil penalty amounts) for deceptive advertising. This includes claims about disease treatment, cure, or prevention without adequate scientific evidence. The FTC has been increasingly active in supplement enforcement, particularly around weight loss, immune support, and cognitive health claims.

Who is responsible if a supplement causes harm: the brand or the manufacturer?

Both can be held liable. The brand owner (whose name is on the label) typically faces the most direct consumer liability. The manufacturer can be liable under product liability law. Your manufacturing agreement should address indemnification and insurance requirements. Both parties should carry product liability insurance.

How do I check if my manufacturer has FDA violations?

Search the FDA's public databases: Warning Letters (fda.gov/inspections-compliance), Form 483 observations (via FOIA request), Import Alerts, and Recall databases. FDA facility registration records are confidential and not publicly searchable, so request registration confirmation directly from the facility. NSF and other third-party certifiers maintain their own compliance records.

Greg Huang, Founder of multiple consumer brands in the dietary supplement and nutrition industry since 2009

Founder of Inventory Ready. Previously founded and operated multiple consumer brands in the dietary supplement and nutrition industry since summer 2009.

Concepts Covered

FDA Warning Letter FDA Inspection Structure/Function Claims 21 CFR Part 111 cGMP (Current Good Manufacturing Practice)Proposition 65 (California)

Disclaimer: This guide is educational content, not legal or regulatory advice. Compliance requirements are complex and vary by product, ingredients, claims, and target markets. Consult with a qualified regulatory attorney and compliance professional before making decisions. See our Terms of Service for details.